---
title: "Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294684783.md"
description: "Expanded reimbursement under the New Technology Add-on Payment program is expected to increase accessibility to a unique dual seizure and delirium monitoring platform. This development will significantly benefit patients, as well as healthcare providers, by enhancing access to innovative healthcare solutions. The increase in reimbursement stands to impact a large number of individuals seeking improved monitoring and care, further highlighting the potential positive outcomes of this program expansion."
datetime: "2026-08-03T11:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294684783.md)
  - [en](https://longbridge.com/en/news/294684783.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294684783.md)
generator: "portal-rs"
---

# Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Expanded reimbursement under the New Technology Add-on Payment program is expected to increase accessibility to a unique dual seizure and delirium monitoring platform. This development will significantly benefit patients, as well as healthcare providers, by enhancing access to innovative healthcare solutions. The increase in reimbursement stands to impact a large number of individuals seeking improved monitoring and care, further highlighting the potential positive outcomes of this program expansion.

### Related Stocks

- [CBLL.US](https://longbridge.com/en/quote/CBLL.US.md)

## Related News & Research

- [Ceribell Senior VP Finance David Foehr disposes of 1,852 common shares worth $44,586.29](https://longbridge.com/en/news/297037166.md)
- [Ceribell CEO Xingjuan Chao sells 33,614 shares for $896,982.42](https://longbridge.com/en/news/296543326.md)
- [Insider Selling: CeriBell (NASDAQ:CBLL) CFO Sells $24,750.00 in Stock](https://longbridge.com/en/news/296551659.md)
- [Sera Prognostics says PRIME trial shows PreTRM-guided care cuts preterm births before 32 weeks by over 50%](https://longbridge.com/en/news/296910866.md)
- [CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push](https://longbridge.com/en/news/295682774.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**